Factors influencing the gut-brain axis

This post is specifically for health practitioners. Create a free account

Alternatively, view general public info.

Learn more about vital.ly

Download summary sheet PDF (To download, hover over the link, right click on your mouse and select "Save as".)  

 

Factors influencing the microbiome and gut-brain axis

Dietary components

Dietary fibre

  • There is now overwhelming evidence of the health benefits of dietary fibre consumption and its association with high concentrations of short-chain fatty acids (SCFAs) in the gut (1)
  • The microbiome depends on dietary fibre to thrive and consumption of dietary fibre appears to be a critical determinant for gut bacterial ecology, diversity, and function (2). Consumption of dietary fibre has a direct effect on the microbiome composition (3)
  • Bacterial fermentation of dietary fibre generates SCFAs such as butyrate, an essential metabolite for intestinal homeostasis (4). Butyrate is the preferred energy source for colonocytes, contributes to gut barrier integrity and suppresses gut inflammation. A diet lacking in fibre can lead to chronic GI inflammation and a compromised gut barrier (3)

Dietary protein

  • Dietary protein serves as the major source of nitrogen for colonic microbial growth and is essential to the assimilation of carbohydrates and production of beneficial products such as SCFAs. Hence, a combination of protein and carbohydrates in the large bowel can contribute to bowel health (5)
  • High-protein diets, however, increase detrimental metabolites in faeces and high intake of animal protein is associated with an increased risk of IBD (6)
  • The gut microbiota is affected by excess protein fermentation in the colon. The effect of protein digestion is determined by the amount and source of protein. Dietary strategies with judicious selection of source and supplementation of dietary protein to benefit gut health are important (7)

Dietary fat

  • Several in vivo studies have shown that a high-fat diet is associated with a decrease in butyrate-producing bacteria and increased GI inflammation. Dietary fats, particularly trans and saturated fats, also alter diurnal patterns of gut microbiota structure and function (3,8)
  • Omega-3 polyunsaturated fatty acids (n-3-PUFAs), primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may improve or prevent some neurological and neuroimmune disorders (for example, depression and AD) (3)
  • A randomized trial found that supplementation with n-3-PUFA induces a reversible increase in several SCFA-producing bacteria (9)
  • These observations suggest that n-3-PUFA supplementation may represent an effective way to modify the production of SCFAs and in turn improve GI homeostasis (3)
  • DHA and EPA are available commercially as purified supplements, however, they are present in high quantities in fish, especially cold-water fatty fish, such as salmon, mackerel, low-mercury tuna, herring and sardines

Dietary polyphenols

  • A novel and relevant strategy in reducing neuroinflammation and oxidative stress, improving memory and cognitive function, as well as modulating the gut microbiota, making them promising nutraceuticals to combat neurological disorders (10)
  • Abundant in fruits, vegetables, red wine, green and black tea (3)
  • Citrus flavanones (e.g. hesperidin and naringin) are able to influence the microbiota composition and activity and exert beneficial effects on intestinal barrier function and gastrointestinal inflammation (11)
  • While studies clearly underscore the potential benefits of polyphenols in modifying and modulating the gut microbiota, most of these studies have been carried out using experimental models. Therefore, more clinical trials are needed to fully appreciate their benefit (3)

Vitamins

Vitamin A

  • Plays an important role in neurological function as well as regulating the CNS development
  • Promotes intestinal immunity and maintains gut barrier integrity
  • Influences the microbiome profile, including in children with ASD (3,12,13)

Vitamin D

  • Several neuroimmune and neuroinflammatory diseases which are associated with microbiome alterations such as MS, ASD and AD, have been associated with vitamin D deficiency (3)
  • Evidence for the efficacy of vitamin D in altering the microbiota in neuroimmune and neuroinflammatory diseases is limited and supported by indirect evidence, however, there is substantial evidence supporting its role in maintaining GI homeostasis by regulating mucosal inflammatory responses and maintaining intestinal barrier function (3)

B Vitamins

  • B vitamins are acquired through diet or from the gut microbiota, and their deficiencies are often found in patients with intestinal malabsorption. B vitamin deficiencies lead to deleterious neurological effects including polyneuropathy, diabetic polyneuropathy, optic atrophy, myelopathy and cerebellar ataxia (3)
  • Vitamin B12 is made in significant quantities by commensal bacteria in the large intestine; however, the necessary transport receptors in humans are primarily in the small intestine, suggesting that the B12 produced by the microbiota is primarily consumed by the microbiota. Accordingly, B12 supplementation may represent an effective way to modulate the gut microbiota, particularly in the small intestine (14)

Probiotics

  • Probiotics have recently attracted attention in the context of brain function and health because they serve to alter gut microflora toward a beneficial state, which could affect the gut-brain axis (15). Certain probiotics may positively impact the pathogenesis of neurological disorders, however, most of the studies are based on indirect evidence (3)
  • A recent meta-analysis concluded that probiotics may have a positive effect on psychological symptoms in healthy individuals, however, the effect may be significantly reduced in individuals suffering from existing chronic conditions, particularly those associated with dysbiosis, immune function changes and psychological comorbidities such as IBS and rheumatoid arthritis (16)
  • The term ‘psychobiotics’ is defined as any live organism that, when ingested in adequate amounts, produces a health benefit in patients suffering from psychiatric illness (17)
  • Psychobiotics are by definition a subgroup of probiotics with the added emphasis on mental illness. Most psychobiotics are capable of producing or promoting the endogenous synthesis of neurotransmitters which influence the gut-brain axis and mental health. Biogenic amines implicated in neuroimmune disease pathology, such as brain-derived neurotrophic factor (BDNF), dopamine, gamma-aminobutyric acid (GABA) and glutamate, are influenced by gut microbes (3)
  • Fermented foods may be a useful dietary strategy for mental and brain health (8)
  • Consuming probiotics from the Bifidobacterium and Lactobacillus genera reduces negative mood in healthy individuals (18)

Harmful dietary components

  • It is important to consider the emerging evidence regarding the harmful impact of components of ‘junk’ and processed foods, including dietary emulsifiers, artificial sweeteners and high-fat, refined-sugar diets on gut and brain health (23)
  • Emulsifiers, compounds commonly used in a variety of foods, promote gut microbiota alteration and gut barrier dysfunction, leading to negative metabolic alterations resulting in weight gain low-grade inflammation and metabolic disorders (24)
  • Artificial sweetener consumption has been linked to gut dysbiosis and metabolic abnormalities (9,25)
Loading...
References
1Zhang N, Ju Z, Zuo T. Time for food: The impact of diet on gut microbiota and human health. Nutrition. 2018 Jul;51–52:80–5.
2Tan J, McKenzie C, Vuillermin PJ, Goverse G, Vinuesa CG, Mebius RE, et al. Dietary Fiber and Bacterial SCFA Enhance Oral Tolerance and Protect against Food Allergy through Diverse Cellular Pathways. Cell Rep. 2016 21;15(12):2809–24.
3Lombardi VC, De Meirleir KL, Subramanian K, Nourani SM, Dagda RK, Delaney SL, et al. Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease. The Journal of Nutritional Biochemistry. 2018 Nov;61:1–16.
4Williams BA, Grant LJ, Gidley MJ, Mikkelsen D. Gut Fermentation of Dietary Fibres: Physico-Chemistry of Plant Cell Walls and Implications for Health. Int J Mol Sci. 2017 Oct 20;18(10).
5Conlon MA, Bird AR. The Impact of Diet and Lifestyle on Gut Microbiota and Human Health. Nutrients. 2014 Dec 24;7(1):17–44.
6Salonen A, de Vos WM. Impact of diet on human intestinal microbiota and health. Annu Rev Food Sci Technol. 2014;5:239–62.
7Ma N, Tian Y, Wu Y, Ma X. Contributions of the Interaction Between Dietary Protein and Gut Microbiota to Intestinal Health. Curr Protein Pept Sci. 2017;18(8):795–808.
8Bruce-Keller AJ, Salbaum JM, Berthoud H-R. Harnessing Gut Microbes for Mental Health: Getting From Here to There. Biological Psychiatry. 2018 Feb;83(3):214–23.
9Watson H, Mitra S, Croden FC, Taylor M, Wood HM, Perry SL, et al. A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota. Gut. 2018;67(11):1974–83.
10Serra D, Almeida LM, Dinis TCP. Dietary polyphenols: A novel strategy to modulate microbiota-gut-brain axis. Trends in Food Science & Technology. 2018 Aug;78:224–33.
11Stevens Y, Rymenant EV, Grootaert C, Camp JV, Possemiers S, Masclee A, et al. The Intestinal Fate of Citrus Flavanones and Their Effects on Gastrointestinal Health. Nutrients. 2019 Jun 27;11(7):1464.
12Lee H, Ko G. New perspectives regarding the antiviral effect of vitamin A on norovirus using modulation of gut microbiota. Gut Microbes. 2017 Aug 3;8(6):616–20.
13Liu J, Liu X, Xiong X-Q, Yang T, Cui T, Hou N-L, et al. Effect of vitamin A supplementation on gut microbiota in children with autism spectrum disorders - a pilot study. BMC Microbiol. 2017 Sep 22;17.
14Degnan PH, Taga ME, Goodman AL. Vitamin B 12 as a Modulator of Gut Microbial Ecology. Cell Metabolism. 2014 Nov;20(5):769–78.
15Kim N, Yun M, Oh YJ, Choi H-J. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics. J Microbiol. 2018 Mar;56(3):172–82.
16McKean J, Naug H, Nikbakht E, Amiet B, Colson N. Probiotics and Subclinical Psychological Symptoms in Healthy Participants: A Systematic Review and Meta-Analysis. J Altern Complement Med. 2017 Apr;23(4):249–58.
17Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013 Nov 15;74(10):720–6.
18Sarkar A, Harty S, Lehto SM, Moeller AH, Dinan TG, Dunbar RIM, et al. The Microbiome in Psychology and Cognitive Neuroscience. Trends in Cognitive Sciences. 2018 Jul;22(7):611–36.
19Kim N, Yun M, Oh YJ, Choi H-J. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics. J Microbiol. 2018 Mar;56(3):172–82.
20McKean J, Naug H, Nikbakht E, Amiet B, Colson N. Probiotics and Subclinical Psychological Symptoms in Healthy Participants: A Systematic Review and Meta-Analysis. J Altern Complement Med. 2017 Apr;23(4):249–58.
21Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013 Nov 15;74(10):720–6.
22Sarkar A, Harty S, Lehto SM, Moeller AH, Dinan TG, Dunbar RIM, et al. The Microbiome in Psychology and Cognitive Neuroscience. Trends in Cognitive Sciences. 2018 Jul;22(7):611–36.
23Sun M-F, Shen Y-Q. Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease. Ageing Research Reviews. 2018 Aug;45:53–61.
24Kim Y-K, Shin C. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments. Curr Neuropharmacol. 2018;16(5):559–73.
25Kharrazian D. Traumatic Brain Injury and the Effect on the Brain-Gut Axis. Altern Ther Health Med. 2015 Aug;21 Suppl 3:28–32.
26Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PWJ. Psychobiotics and the Manipulation of Bacteria–Gut–Brain Signals. Trends in Neurosciences. 2016 Nov;39(11):763–81.
27Yang Y, Tian J, Yang B. Targeting gut microbiome: A novel and potential therapy for autism. Life Sciences. 2018 Feb;194:111–9.